Collectively, these results demonstrated that in addition to immune cell infiltration, tumor immune escape mediated by immune checkpoints and CAFs is also involved in CAMSAP1-mediated LIHC progression and ICB treatment is effective in these patients. Here, CAMSAP1 is linked to neoplasm.